Literature DB >> 20621641

Correlates of cognitive dysfunction in multiple sclerosis.

C Heesen1, K H Schulz, J Fiehler, U Von der Mark, C Otte, R Jung, J Poettgen, T Krieger, S M Gold.   

Abstract

Cognitive impairment is one of the most frequent symptoms in patients with multiple sclerosis (MS) but its underlying mechanisms are poorly understood. A number of pathogenetic correlates have previously been proposed including psychosocial factors (such as depression and fatigue), inflammation, neurodegeneration, and neuroendocrine dysregulation. However, these different systems have never been studied in parallel and their differential contributions to cognitive impairment in MS are unknown. We studied a well-characterized cohort of cognitively impaired (CI, n=25) and cognitively preserved (CP, n=25) MS patients based on a comprehensive neuropsychological testing battery, a test of hypothalamo-pituitary-adrenal axis functioning (dexamethasone-corticotropin-releasing hormone suppression test, Dex-CRH test) as well as peripheral blood and MRI markers of inflammatory activity. CI patients had significantly higher disability. In addition, CI patients showed higher levels of fatigue and depression. Fatigue was more closely associated with measures of attention while depression showed strongest correlations with memory tests. Furthermore, percentage of IFNγ-positive CD4+ and CD8+ T cells showed modest correlations with processing speed and working memory. MRI markers of inflammation or global atrophy were not associated with neuropsychological function. Compared to previous studies, the number of patients exhibiting HPA axis hyperactivity was very low and no correlations were found with neuropsychological function. We conclude that fatigue and depression are the main correlates of cognitive impairment, which show domain-specific associations with measures of attention and memory.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621641     DOI: 10.1016/j.bbi.2010.05.006

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  28 in total

Review 1.  Inflammation and adaptive immunity in Parkinson's disease.

Authors:  R Lee Mosley; Jessica A Hutter-Saunders; David K Stone; Howard E Gendelman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

2.  Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study.

Authors:  Jeffrey Wilken; Robert L Kane; Cynthia L Sullivan; Mark Gudesblatt; Sylvia Lucas; Robert Fallis; Xiaojun You; Pam Foulds
Journal:  Int J MS Care       Date:  2013

3.  Chronic mild stress eliminates the neuroprotective effect of Copaxone after CNS injury.

Authors:  Igor Smirnov; James T Walsh; Jonathan Kipnis
Journal:  Brain Behav Immun       Date:  2013-01-04       Impact factor: 7.217

4.  Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer.

Authors:  Debra E Lyon; Ronald Cohen; Huaihou Chen; Debra L Kelly; Nancy L McCain; Angela Starkweather; Hyochol Ahn; Jamie Sturgill; Colleen K Jackson-Cook
Journal:  J Neuroimmunol       Date:  2016-11-13       Impact factor: 3.478

5.  Biological outcome measurements for behavioral interventions in multiple sclerosis.

Authors:  Anja Fischer; Christoph Heesen; Stefan M Gold
Journal:  Ther Adv Neurol Disord       Date:  2011-07       Impact factor: 6.570

6.  Utility of the INECO frontal screening (IFS) in the detection of executive dysfunction in patients with relapsing-remitting multiple sclerosis (RRMS).

Authors:  D Bruno; T Torralva; V Marenco; J Torres Ardilla; S Baez; E Gleichgerrcht; V Sinay; M Roca
Journal:  Neurol Sci       Date:  2015-06-26       Impact factor: 3.307

7.  Dynamic development of glucocorticoid resistance during autoimmune neuroinflammation.

Authors:  Stefan M Gold; Manda V Sasidhar; Venu Lagishetty; Rory D Spence; Elizabeth Umeda; Marina O Ziehn; Thorsten Krieger; Karl-Heinz Schulz; Christoph Heesen; Martin Hewison; Rhonda R Voskuhl
Journal:  J Clin Endocrinol Metab       Date:  2012-06-01       Impact factor: 5.958

8.  Fatigue is associated with high prevalence and severity of physical and emotional symptoms in patients on chronic hemodialysis.

Authors:  Maurizio Bossola; Enrico Di Stasio; Emanuele Marzetti; Katja De Lorenzis; Gilda Pepe; Carlo Vulpio
Journal:  Int Urol Nephrol       Date:  2018-05-04       Impact factor: 2.370

Review 9.  [Therapy of fatigue in multiple sclerosis : A treatment algorithm].

Authors:  C Veauthier; F Paul
Journal:  Nervenarzt       Date:  2016-12       Impact factor: 1.214

Review 10.  Targeting the gut to treat multiple sclerosis.

Authors:  Laura Ghezzi; Claudia Cantoni; Gabriela V Pinget; Yanjiao Zhou; Laura Piccio
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.